Jazz obtains exclusive worldwide rights to develop and commercialize preclinical asset SAN2355 in epilepsy and other ...

Spring Bio Solution will offer OneScan to pharmaceutical manufacturers across India, Europe, Singapore, and other key global ...

Nucleus RadioPharma, a contract development and manufacturing organization (CDMO) specializing in radiopharmaceuticals, has ...

Schreiner MediPharm has partnered with Bluesight to launch an RFID-based system for digital inventory control in hospital ...

The initiative aims to identify and support new ideas for innovative oral formulations for peptide drugs such as GLP-1 ...

Altasciences has received a sustainability Gold Medal from EcoVadis, placing it in the 96th percentile and among the top 5% ...

Wegovy is now positioned as the first and only GLP-1 treatment.

FDA states substantial evidence of efficacy was not demonstrated.

IQVIA and Veeva Systems announced global clinical and commercial partnerships and the complete resolution of all pending ...

Developed by Daiichi Sankyo and Merck, it treats patients with Pretreated Extensive-Stage Small Cell Lung Cancer.

Systlmmune and BMS’ ACD treats patients with previously treated Advanced EGFR-Mutated Non-Small Cell Lung Cancer.

In partnership with the University of Oxford’s Pandemic Sciences Institute, the grant will advance oral vaccine delivery.